A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

This post was just published on ZYX Buy Change Alert.

On February 1st we issued a call to take profits on MNTA.  Depending upon how you traded, your profits would have been 74%.

We got out at the top.  Now the stock has fallen providing an opportunity to enter again.  The buy zone is $12 to $15.35, preferably below $14.31.  The stock is trading at $15.30 as of this writing. The target zone is $18 to $20, and $24 to $28 in the event of a buyout.  Stop zone on one-half of the position is $11 to $11.38.

Those who are not aggressive may consider accumulating only on a dip in the $12 range.

Recommended quantity is 30% of the full core position size.

MNTA is in the business of biosimilars.  In the world of biotechnology, biosimilars are just like generics in the traditional pharmaceutical world.  The difference is that making a biosimilar is much more difficult than making a generic.

Most of the movements in this stock result from ups and downs related to its drug Glatopa.  Glatopa is a biosimilar to Copaxone.  Copaxone is a highly popular MS drug from TEVA.

The drop in MNTA stock has resulted from an FDA warning letter to PFE.  PFE is the manufacturing partner for MNTA.

In our analysis, PFE should be able to resolve the issue in the near future.  However the risk in MNTA stock has increased as other companies are on its heels to develop a biosimilar for Copaxone.  For this reason those who are not aggressive need to wait for a dip into the $12 range; of course such a dip may never happen.  Those who are aggressive may consider scaling in by starting a very, very small position right here.  Please see Trade Management Guidelines.

 

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

WEEKLY MARKET DIGEST: GOLD AT RECORD HIGH AS INVESTORS MOVE TO PROTECT STOCK MARKET PORTFOLIOS $DJIA $SPX $QQQ $GLD $SLV $USO $GDX $AZN

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

VACCINE IS GOOD FOR EVERYBODY BUT NOT FOR YOUR FAVORITE STOCKS $INO $PFE $NVAX $NIO $MRNA $AZN $TSLA $AMZN $DIA $DJIA $FSLY $PTON $ZM $DOCU $MSFT $GOOG $NFLX

We all want a safe and effective vaccine for the coronavirus. Certainly one or more effective vaccines will be good ...

WEEKLY MARKET DIGEST: A BREAK ABOVE THE UPPER BAND, RECORD COMPLACENCY AMONG TRADERS $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

WEEKLY MARKET DIGEST: BACKWARD LOOKING STRONG JOBS NUMBER REINFORCES THE NOTION — STOCKS ONLY GO UP $DIA $GLD $QQQ $SLV $SPY $TBT $USO $PFE $MJ $MRNA

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

POLITICIANS SET UP THE STOCK MARKET FOR A JULY FALL — MORE BORROWING AND MONEY PRINTING AHEAD $CCL $AAL $DIA $SPY $SPX $PFE $BNTX $NVAX $MRNA $INO

The stock market has been detached from economic reality. Investors, drunk with “hopium,” bored at home and unable to bet ...

WEEKLY MARKET DIGEST: POTENTIAL VIRUS MUTATION, CHINA HONG KONG POWER GRAB CHALLENGES TRUMP – STOCK MARKET OBLIVIOUS $DIA $GLD

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

VACCINE SUCCESS MAY UNLEASH THE SECOND LEG OF THE FORCE TO PROPEL THE STOCK MARKET TO NEW HIGHS $JNJ $PFE $MRNA $NVAX $INO $SRNE $DIA

Many investors not familiar with the mechanics of short squeezes are confused by the strength of the stock market rally ...

WEEKLY MARKET DIGEST: HERE IS WHAT SMART MONEY IS DOING WITH STOCKS, GOLD, OIL AND MARIJUANA $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

WEEKLY MARKET DIGEST: SHORT SQUEEZE AND QUADRUPLE WITCHING STOCK MARKET RALLY FAILED AS WE HAD CALLED $DIA $GLD $QQQ $SLV $SPY $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

CHLOROQUINE CAN POTENTIALLY TRIGGER A 5000 POINT RALLY IN THE STOCK MARKET $AAL $AAPL $AMD $AMZN $BAC $DIA $DJIA $GILD $INTC $JPM $LUV $MYL $SPX $TEVA $BAYRY

Investors, after facing huge losses amid the threat of the coronavirus, are grappling with what is next for the stock ...

BIOTECHS ARE HOT PRODUCING OUTSIZED GAINS — GET YOUR SHARE $GSK $GBT $MRK $SPY $DJIA $ICPT $THOR $ARQL $BHVN $CLVS $AMZN $JNJ $PHE $NVS $SNY

New developments in clinical trials and drug approvals have become commonplace. And buyouts of biotech stocks at high premiums are ...

WEEKLY MARKET DIGEST: WALL STREET POSITIVE ON IMPEACHMENT, MARIJUANA BANKING, BEST MOVE IN INDIAN STOCKS $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

FIVE IMPORTANT POINTS EVERY PRUDENT INVESTOR OUGHT TO CONSIDER ABOUT TRUMP IMPEACHMENT $SPY $AMZN $JPM $MU $CAT $UNH $GLD $MRK

The House of Representatives has started an impeachment inquiry into President Trump. What does that mean for investors? First and foremost, ...

WEEKLY MARKET DIGEST: HIGHER CONSUMER SPENDING BUT LOWER PERSONAL INCOME, GOLD SOLD, CRUDE OIL BUILD, HIGHER STOCKS $DIA $GLD $QQQ $SLV $SPY

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

HOW DEMOCRATIC OR REPUBLICAN WINS COULD DIVIDE TECH STOCKS INTO WINNERS AND LOSERS $ITA $LMT $NOC $BA $RTN $UTX $CAT $CNC $AAPL $AMZN $CELG $REGN $FB

Today is the last day to save $2,605.  Character of the market is changing. What worked in the last nine ...

A NEW IDEA ON BIOTECH COMPANY ACORDA ON PATENT INVALIDATION $ACOR $MYL $TEVA

These posts were published on ZYX Short Sell Change Alert. The short zone for Acorda Therapeutics (ACOR) is $24.50 to $26.40.  Since the ...

INVESTORS OUGHT TO GET AHEAD OF TRUMP’S TAX-REFORM PUSH $SPY $AMZN $LUV $AAPL $MSFT $GOOG $SCHW $DGX $CVS $CSCO $WDC $CAT $PFE $RL $PAYX

President Trump’s economic adviser, Gary Cohn, said that starting this week the administration expects to launch a tax campaign that ...

BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly ...

WHAT COULD PUSH STOCKS EVEN HIGHER? TRUMP’S LATEST IDEA $AAPL $GLD $SLV $DUST $SPY $YM_F $PFE $GOOG $FB $SHOP

In my 30-plus years in the markets, I can safely say that most popular analysis methods do not work well. ...

UPDATE ON BIOTECH BEAR ETF LABD $LABD $LABU $PPH $PJP $PFE $JNJ $MRK $BMY $BBH $IBB $XBI

This post was just published on ZYX Buy Change Alert. In our divided country there are very few things on which Republicans and ...

Follow

Get every new post delivered to your Inbox

Join other followers